(Q24550631)

English

Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089718%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

0 references

1 reference

Europe PubMed Central

Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089718%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

prostate cancer

1 reference

based on heuristic

inferred from title

Richard M Hoffman

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089718%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Benjamin Littenberg

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089718%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

D L Clanon

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089718%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J J Frank

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089718%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J C Peirce

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089718%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

0 references

publication date

1 October 2000

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089718%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Journal of General Internal Medicine

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089718%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

15

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089718%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089718%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

739-748

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089718%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

describes a project that uses

1 reference

Europe PubMed Central

18 June 2022

https://europepmc.org/article/PMC/1495603

based on heuristic

inferred from PubMed Central ID database lookup

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

24 March 2017

Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

24 March 2017

Spectrum Bias in the Evaluation of Diagnostic Tests: Lessons from the Rapid Dipstick Test for Urinary Tract Infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

24 March 2017

Problems of spectrum and bias in evaluating the efficacy of diagnostic tests

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

24 March 2017

Prostate-specific antigen: current status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Prostate cancer detection at low prostate specific antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

The role of free prostate-specific antigen in the diagnosis of prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Free and total prostate-specific antigen in a screened population.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Free to total prostatic specific antigen ratio as a new diagnostic tool in prostatic carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Percentage of free serum prostate-specific antigen: a new tool in the early diagnosis of prostatic cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

The ratio of free to total serum prostate specific antigen and its use in differential diagnosis of prostate carcinoma in Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Does free to total ratio of prostate-specific antigen alter decision-making on prostatic biopsy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Multicenter comparison of the diagnostic performance of free prostate-specific antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Prospective use of free PSA to avoid repeat prostate biopsies in men with elevated total PSA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Significance of serum free prostate specific antigen in the screening of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Screening for prostate cancer using serum prostate-specific antigen: a randomised, population-based pilot study in Finland

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Integrating stratum-specific likelihood ratios with the analysis of ROC curves

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Risk factors for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Use of methodological standards in diagnostic test research. Getting better but still not good.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Repeat prostate needle biopsy: who needs it?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.90907.X

21 January 2018

The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer: results of a large screening study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Assessing quality of a diagnostic test evaluation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Screening for prostatic carcinoma with prostate specific antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Clinical utility of measurements of free and total prostate-specific antigen (PSA): a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Molecular forms of serum prostate-specific antigen. The clinical value of percent free prostate-specific antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Percent free prostate-specific antigen: entering a new era in the detection of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

27 September 2017

Progress in standardization of immunoassays for prostate-specific antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

30 May 2018

Can free and total prostate specific antigen and prostatic volume distinguish between men with negative and positive systematic ultrasound guided prostate biopsies?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

30 May 2018

Stability of free prostate-specific antigen in serum samples under a variety of sample collection and sample storage conditions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

30 May 2018

Reference test errors bias the evaluation of diagnostic tests for ischemic heart disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

30 May 2018

Clinical evaluation of gamma-seminoprotein in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

30 May 2018

Prevalence and pathological extent of prostate cancer in men with prostate specific antigen levels of 2.9 to 4.0 ng./ml

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.90907.X

21 January 2018

Guidelines for meta-analyses evaluating diagnostic tests.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.90907.X

21 January 2018

Clinical usefulness of free PSA fraction as an indicator of prostate cancer.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.90907.X

21 January 2018

Comparability of the tandem-R andIMx assays for the measurement of serum prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.90907.X

21 January 2018

The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

28 November 2018

A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates: the best case scenario

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495603

28 November 2018

Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-label time-resolved immunofluorometric assay of prostate-specific antigen and of its complex with alpha 1-antichymotrypsin

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of prostate specific antigen and gamma-seminoprotein ratio: a new means of distinguishing benign prostatic hyperplasia and prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimating Diagnostic Accuracy from Multiple Conflicting Reports

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analytical performance and clinical validity of two free prostate-specific antigen assays compared

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary clinical evaluation of free/total PSA ratio by the IMMULITE system

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Free-to-total prostate specific antigen ratio as a single test for detection of significant stage T1c prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Free-to-total prostate-specific antigen serum concentrations in patients with prostate cancer and benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Free and complexed prostate-specific antigen serum ratios to predict probability of primary prostate cancer and benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of three assays for total serum prostate-specific antigen and percentage of free prostate-specific antigen in predicting prostate histology

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Free to total prostate-specific antigen (PSA) ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia (BPH) in the diagnostic gray zone of 1.8 to 10 ng/mL total PSA

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening for prostate cancer. American College of Physicians

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary results of clinical evaluation of the free/total prostate-specific antigen ratio in a multicentric study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of repeat sextant biopsies in prostate cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement of prostate cancer screening by determination of the ratio free/total PSA in addition to PSA levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of the enzymatic activity of prostate-specific antigen and its reactions with extracellular protease inhibitors in prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical usefulness of free and complexed PSA

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual monoclonal antibody immunoassay for free prostate-specific antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of the determination of noncomplexed prostate-specific antigen as a marker for prostate carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The proportion of free to total prostate specific antigen: a method of detecting prostate carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Issues in the assessment of prostate-specific antigen immunoassays. An update

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variation of free and total prostate-specific antigen levels: the effect on the percent free/total prostate-specific antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological variation of total, free and percent free serum prostate specific antigen levels in screening volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of free PSA in the diagnosis and staging of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of prostate-specific antigen (PSA) measured by four combinations of free PSA and total PSA assays

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stability of serum total and free prostate specific antigen under varying storage intervals and temperatures

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of a screening test and a reference test in epidemiologic studies. I. Indices of agreement and their relation to prevalence

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/11089718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2000.90907.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1046/J.1525-1497.2000.90907.X

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089718%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Dimensions Publication ID

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089718%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11089718%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24550631&oldid=2176811145"